Skip to main content
Fig. 5 | Hereditas

Fig. 5

From: Integrated multi-omics analysis and machine learning refine molecular subtypes and clinical outcome for hepatocellular carcinoma

Fig. 5

Clinical correlations analysis of CMLBS model. (A-E). Differences in CMLBS between groups with different clinical features. (F-K). OS KM curves for CMLBS in the two groups stratified by clinicopathologic factors. (L). The GO pathway enrichment analysis of the high-CMLBS group. (M). The KEGG pathway enrichment analysis of the high-CMLBS group. (N). The GO pathway enrichment analysis of the low-CMLBS group. (O). The KEGG pathway enrichment analysis of the low-CMLBS group

Back to article page

Hereditas

ISSN: 1601-5223

Contact us